Ceprate SC system to separate patients' CD34+ stem and progenitor cells and insert into them the gene for multidrug resistance: Began Phase I/II trial to test s

CellPro Inc. (CPRO), Bothell, Wash. Product: Ceprate SC system to separate patients' CD34+ stem and progenitor cells and insert into them the gene for multidrug resistance (MDR-1), which codes for a c...